Pricing

Athenex Inc (ATNXQ)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Yiu N. Lau
Employees:
670
1001 MAIN STREET, SUITE 600, BUFFALO, NY, 14203
716-898-8625
Stock Split History
DateRatio
2023-02-15 1:20
Athenex, Inc. engages in the discovery, development, and commercialization of drugs for the treatment of cancer. The company's Orascovery product candidates include Oral paclitaxel and encequidar, an oral dosage form, which is in Phase III trial for metastatic breast cancer. It also offers Tirbanibulin ointments for actinic keratosis, skin cancers, and psoriasis.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available